Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception

The primary aim of the present study was to determine the therapeutic dose of subcutaneous levonorgestrel (LNG) to induce azoospermia or severe oligozoospermia (

Saved in:
Bibliographic Details
Published in:International journal of andrology 2001-12, Vol.24 (6), p.369-380
Main Authors: PÖLLÄNEN, Pasi, NIKKANEN, Vesa, HUHTANIEMI, Ilpo
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Birth control
Contraceptive Agents, Male - administration & dosage
Contraceptive Agents, Male - therapeutic use
Dihydrotestosterone - administration & dosage
Dihydrotestosterone - therapeutic use
Drug Implants
Drug Therapy, Combination
Gynecology. Andrology. Obstetrics
Hormonal contraception
Humans
Levonorgestrel - administration & dosage
Levonorgestrel - therapeutic use
Male
Medical sciences
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The primary aim of the present study was to determine the therapeutic dose of subcutaneous levonorgestrel (LNG) to induce azoospermia or severe oligozoospermia (
ISSN:0105-6263
1365-2605
DOI:10.1046/j.1365-2605.2001.00319.x